# Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

> **NCT00978588** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 36 (actual)

## Conditions studied

- Mitral Valvular Heart Disease

## Interventions

- **DRUG:** 6% hydroxyethyl starch 130/0.4 and 5% albumin

## Key facts

- **NCT ID:** NCT00978588
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2009-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978588, "Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00978588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*